TY - JOUR
T1 - Radiofrequency Microneedling
T2 - A Comprehensive and Critical Review
AU - Tan, Marcus G.
AU - Jo, Christine E.
AU - Chapas, Anne
AU - Khetarpal, Shilpi
AU - Dover, Jeffrey S.
N1 - Publisher Copyright:
© 2021 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - BACKGROUNDMany studies have evaluated radiofrequency microneedling (RFMN) in various dermatologic conditions. However, the efficacy and safety of RFMN, and how it compares with other energy-based devices in a clinician's armamentarium, remains unclear.OBJECTIVETo review higher-quality evidence supporting RFMN and the dermatologic conditions which it can be used in.MATERIALS AND METHODSA search was conducted in MEDLINE and EMBASE from inception to May 13, 2020, using the terms: "radiofrequency microneedling"OR "fractional radiofrequency"OR "radiofrequency needling"OR "radiofrequency percutaneous collagen induction."Only randomized, split body or blinded studies with original data on humans were included. Non-English or non-dermatology-related studies were excluded.RESULTSForty-two higher-quality studies were included after applying the inclusion and exclusion criteria. There were 14 studies for skin rejuvenation, 7 for acne scars, 6 for acne vulgaris, 5 each for striae and axillary hyperhidrosis, 2 for melasma, and 1 each for rosacea, cellulite, and androgenetic alopecia.CONCLUSIONRadiofrequency microneedling is an effective intervention that can be used repeatedly and safely in combination with other treatment modalities and in individuals with darker skin phototypes. Radiofrequency microneedling-induced dermal remodeling and neocollagenesis are slow and progressive but continue to improve even 6 months after treatment.
AB - BACKGROUNDMany studies have evaluated radiofrequency microneedling (RFMN) in various dermatologic conditions. However, the efficacy and safety of RFMN, and how it compares with other energy-based devices in a clinician's armamentarium, remains unclear.OBJECTIVETo review higher-quality evidence supporting RFMN and the dermatologic conditions which it can be used in.MATERIALS AND METHODSA search was conducted in MEDLINE and EMBASE from inception to May 13, 2020, using the terms: "radiofrequency microneedling"OR "fractional radiofrequency"OR "radiofrequency needling"OR "radiofrequency percutaneous collagen induction."Only randomized, split body or blinded studies with original data on humans were included. Non-English or non-dermatology-related studies were excluded.RESULTSForty-two higher-quality studies were included after applying the inclusion and exclusion criteria. There were 14 studies for skin rejuvenation, 7 for acne scars, 6 for acne vulgaris, 5 each for striae and axillary hyperhidrosis, 2 for melasma, and 1 each for rosacea, cellulite, and androgenetic alopecia.CONCLUSIONRadiofrequency microneedling is an effective intervention that can be used repeatedly and safely in combination with other treatment modalities and in individuals with darker skin phototypes. Radiofrequency microneedling-induced dermal remodeling and neocollagenesis are slow and progressive but continue to improve even 6 months after treatment.
UR - https://www.scopus.com/pages/publications/85107091059
U2 - 10.1097/DSS.0000000000002972
DO - 10.1097/DSS.0000000000002972
M3 - Review article
C2 - 33577211
AN - SCOPUS:85107091059
SN - 1076-0512
VL - 47
SP - 755
EP - 761
JO - Dermatologic Surgery
JF - Dermatologic Surgery
IS - 6
ER -